index - Myasthenia Gravis: étiologie, physiopathologie & approches thérapeutiques Accéder directement au contenu

Dernières publications

Chiffres clés

55 Publications avec texte intégral

Open Access

46 %

Mots clés

Autoimmunity Inflammation Neuromuscular junction Germinal centers Th17 Muscle regeneration Innate immunity Interferonopathy Macrophages Exercise Autoimmune disease Transcriptome MYB BAFF Experimental autoimmune myasthenia gravis EAMG Germinal centers Interféron de type I Etiology Interferon Neuromuscular junction MiR-7 Interferon IFN Th17 cells PBMC Aldehyde dehydrogenase biological marker CD31 antigen CD34 antigen CD45 antigen CD56 antigen adipocyte animal experiment animal model animal tissue antigen expression article cell differentiation cell function cell isolation cell labeling cell population cell selection controlled study endomysium enrichment culture enzyme activity enzyme substrate flow cytometry human human cell human tissue immunofluorescence in vitro study in vivo study mouse muscle biopsy muscle contraction muscle injury nonhuman phenotype skeletal muscle stem cell transplantation Adipogenesis Aldehyde Dehydrogenase Cell Differentiation Cells Cultured Flow Cytometry Humans Immunohistochemistry Muscle Cells Muscle Development Muscle Skeletal Phenotype Ectopic germinal centers Interleukine-23 Myoblasts Thymic epithelial cells Maladie auto-immune Gd T cells Inflammation Acetylcholine receptors CD31 Antimir-150 Interferon type-I Animal models Myasthenia gravis Lamin A/C nuclei Myasthénie grave Complete Freund's adjuvant MiR-125 Early-onset myasthenia gravis Thymoma Anticorps monoclonal Cardiomyopathy Immunity Experimental mouse models B cells COVID-19 MG patients Immunology and Microbiology Section Disease susceptibility CTCF Thymus M3243AG Auto-immunité Glucocorticoids LMNA Heart failure COX2 CCL21 Immunotherapy Genetics Endogenous nucleic acids Acetylcholine receptor antibodies Chemokines Fragile X syndromes Experimental autoimmune myasthenia gravis Centres germinatifs ectopiques CXCL13-CXCR5 Autoimmune diseases Clinical cell transplantation Gender FMR1 Acetylcholine receptor Interferon de type I Autoimmunity DICER Il-23 Cellules th17 Immune regulation Interferon-β Chronicity Quality of life Conduction disease Myasthenia Gravis MG Inflammatory cytokines Chronic inflammation Acides nucléiques endogènes Chemokine Experimental models Max Long-term follow-up Germinal center Interleukin 23 Immune response Adaptive immunity Interferon type I Mass cytometry CyTOF AChR antibodies Genetic associations Human myoblasts Cytokines Ferrites